OpenAlex
PricingAboutJobs
Log inGet started
Work

Discovery of 2-(4-Ureido-piperidin-1-yl)-4-morpholinothieno [3,2-D] Pyrimidines as Orally Bioavailable Phosphoinositide-3-Kinase Inhibitors with In Vitro and In Vivo Antitumor Efficacy in Triple-Negative Breast Cancer

HTML

Year: 2025
Type: article
Source: Journal of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.5c01164
Authors: Shabber Mohammed, Shabu Thakur, Diksha Manhas, Chilakala Nagarjuna Reddy, Abhisheik Eedara, Santosh K. Guru, Ajeet Singh, Mahir Bhardwaj, Vaishnavi Kambhampati, Ramajayan Pandian, Boobalan Gopu, Shashi Bhushan, Ram A. Vishwakarma, Sai Balaji Andugulapati, Shashank K. Singh, Utpal Nandi, Sandip B. Bharate
Institutions: Indian Institute of Integrative Medicine, Council of Scientific and Industrial Research, Academy of Scientific and Innovative Research, Indian Institute of Chemical Technology, Bose Institute
Language: English

Topic: PI3K/AKT/mTOR signaling in cancer
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: triple-negative breast cancer, thienopyrimidines, PI3K p110α, MAPK signaling, apoptosis, cell migration, isoform selectivity, oral bioavailability, MDA-MB-231 xenograft, structure-based drug design
SDG: Good health and well-being

Open Access status: closed

Funder: Council of Scientific and Industrial Research, India
Awards: G3560560345, G6255011972
OpenAlex ID: W4414856496
FWCI: 0.863
Cites: 64
Cited by: 4
Related to: 10
Parts: 2
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms